Documents

CS0120

Sigma-Aldrich

phospho-Akt/PKB (pSer473) ELISA

(pSer473) phospho, sufficient for 96 tests

Synonym(s):
Akt/PKB ELISA
Pricing and availability is not currently available.

usage

sufficient for 96 tests

shipped in

wet ice

storage temp.

2-8°C

Gene Information

human ... AKT1(207)

Looking for similar products? Visit Product Comparison Guide

General description

The assay is a solid-phase sandwich enzyme-linked immunosorbent assay (ELISA). A monoclonal capture antibody specific for the Akt/PKB, regardless of phosphorylation state, has been coated onto the multiwell strips provided with the kit. Standard dilutions and samples are incubated for 2 hours at RT. Akt/PKB antigen binds to the capture antibody. After a wash, a detection antibody specific for the non-phosphorylated or phosphorylated protein is incubated for 1 hr at RT, which results in binding to the immobilized Akt/PKB protein. An anti-rabbit IgG-HRP completes the four-member sandwich. The reaction is visualized by tetramethylbenzidine (TMB) substrate, followed by the stop solution. The intensity of the yellow color, measured in a multiwell plate reader at 450 nm, is directly proportional to the concentration of Akt/PKB in the original sample. The unknown concentrations are calculated from the standard curve run with each assay.

Application

Akt/PKB ELISAs are designed for in vitro quantitative determination of human, mouse and rat Akt/PKB protein in cell lysates. Akt, also known as protein kinase Bα (PKBα) or RAC-PKa, is one of the downstream targets of PI3 Kinase (PI3K). Akt consist of three highly conserved isoforms designated in humans as Akt1, Akt2, and Akt3. Activated Akt acts as a key mediator of signals for cell survival, proliferation, angiogenesis, and a number of metabolic insulin effects. Because of its growth-promoting effects, Akt plays a central role in tumorigenesis. A number of oncogenes and tumor suppressor genes act upstream of Akt to influence cancer progression.

Biochem/physiol Actions

Phospho-Akt/PKB (pSer 473) ELISA is designed to detect and quantify the levels of human, mouse and rat Akt/PKB protein phosphorylated on serine 473. Akt/PKB is recruited from the cytosol to the plasma membrane and upon membrane localization, Akt undergoes a conformational change, which makes it accessible to phosphorylation at two kinase regulatory sites, threonine-308 of the kinase activation segment and serine-473 of the hydrophobic module. Carboxyl-terminal modulator protein (CTMP) binds to Akt/PKB a and reduces the activity by inhibiting phosphorylation at both threonine 308 and serine 473. These findings identify CTMP as a negative regulatory component of the pathway controlling PKB activity.

Features and Benefits

Akt/PKB ELISAs are a fast (total time 4 hours), sensitive (<0.1 ng/ml for non-phosphorylated and <0.8 units/mL for phosphorylated Akt/PKB) and specific (measure total or phosphorylated Akt/PKB with no crossreactivity with p38 MAPK, p42, JNK1 and others) alternative to immunoblotting or bioassays. The kit contains precoated plates and incubations are run at room temperature. No proprietary instrumentation is required.

Analysis Note

The sensitivity is <0.8 units/mL, which is ~2x more sensitive than immunoblotting. The specificity is confirmed by peptide blocking showing that only the phosphopeptide containing the phosphorylated serine 473 blocks the ELISA signal. The same sequence containing non-phosphorylated serine at position 473 did not block the signal.

RIDADR

UN 3316 9/PG 2

Certificate of Analysis
Certificate of Origin

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.